Related Experiment Video
Updated: Feb 24, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Investigating the Genetic Causes of Sudden Unexpected Death in Children Through Targeted Next-Generation Sequencing
Laura J Dewar1, Miguel Alcaide1, Daniel Fornika1
1From the Departments of Biomedical Physiology and Kinesiology (L.J.D., S.S., C.M.S., G.F.T.) and Molecular Biology and Biochemistry (M.A., D.F., L.D., C.M.S., R.D.M., G.F.T.), Simon Fraser University, Burnaby, British Columbia, Canada; BC Children's Hospital Research Institute, Vancouver, Canada (L.J.D., S.S., C.M.S., G.F.T.); Department of Pathology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada (T.B., S.M.P.); and Division of Pediatric Cardiology, Department of Pediatrics, British Columbia Children's Hospital, University of British Columbia, Vancouver, Canada (S.S.).
Background:
Inherited arrhythmia syndromes are responsible for a significant portion of autopsy-negative sudden unexpected death (SUD) cases, but molecular autopsy used to identify potentially causal variants is not routinely included in SUD investigations. We collaborated with a medical examiner's office to assist in finding a diagnosis for their autopsy-negative child SUD cases.
Methods And Results:
191 child SUD cases (<5 years of age) were selected for analyses. Our next generation sequencing panel incorporated 38 inherited arrhythmia syndrome candidate genes and another 33 genes not previously investigated for variants that may underlie SUDY pathophysiology. Overall, we identified 11 potentially causal disease-associated variants in 12 cases, for an overall yield of 6.3%. We also identified 31 variants of uncertain significance in 36 cases and 16 novel variants predicted to be pathogenic in silico in 15 cases. The disease-associated variants were reported to the medical examiner to notify surviving relatives and recommend clinical assessment.
Conclusions:
We have identified variants that may assist in the diagnosis of at least 6.3% of autopsy-negative child SUD cases and reduce risk of future SUD in surviving relatives. We recommend a cautious approach to variant interpretation. We also suggest inclusion of cardiomyopathy genes as well as other candidate SUD genes in molecular autopsy analyses.
More Related Videos
Related Concept Videos
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

